למיזיל טבליות 250 מ"ג

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

TERBINAFINE HYDROCHLORIDE 281.25 MG

Disponible depuis:

NOVARTIS PHARMA SERVICES AG

Code ATC:

D01BA02

forme pharmaceutique:

TABLETS

Mode d'administration:

PER OS

Fabriqué par:

NOVARTIS PHARMACEUTICALS LTD, UK

Groupe thérapeutique:

TERBINAFINE

indications thérapeutiques:

Fungal infections of the skin caused by dermatophytes such as trichophyton (e.g. rubrum, t. mentagrophytes, t. verrucosum, t. violaceum), microsporum canis and epidermophyton floccosum. Oral Lamisil should only be used to treat extensive, severe ringworm infections ( tinea corporis, tinea cruris and tinea pedis). Oral Lamisil is not effective against vaginal candidiasis or pityriasis (tinea) versicolor. Onychomycoses ( tinea unguium, ringworm of the nails) due to infecton with dermatophyte organisms ( hyphomycetes).

Date de l'autorisation:

2009-09-01